ISSN: 1752-6752

Journal Home

Journal Guideline

PharmacoVigilance Review Q4 Unclaimed

Euromed Communications United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

PharmacoVigilance Review is a journal indexed in SJR in Health Policy and Pharmacology, Toxicology and Pharmaceutics (miscellaneous) with an H index of 2. It has an SJR impact factor of 0,11 and it has a best quartile of Q4. It has an SJR impact factor of 0,11.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Health Policy (Q4) Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,11

SJR Impact factor

2

H Index

0

Total Docs (Last Year)

4

Total Docs (3 years)

0

Total Refs

0

Total Cites (3 years)

3

Citable Docs (3 years)

0

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Kesmas Q4
Journal of Clinical Outcomes Management Q4
Physis Q4
Physis (Rio de Janeiro, Brazil) Q4
British Journal of Health Care Management Q4

Compare this journals

PharmacoVigilance Review Q4 Unclaimed

- €

NPD

- €

Metrics

0,11

2

0

4

0

0

3

0

0.0

Comments

Other journals with similar parameters

Aims and Scope

FAQS

What is the impact factor of PharmacoVigilance Review?